Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pirfenidone in Moderate to Severe Acute Pancreatitis
NCT05350371Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Aug 2023
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pirfenidone in acute pancreatitis (AP), sponsored by University of Alabama at Birmingham. Started Aug 2023; status: completed.
02
Drugs
pirfenidone
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT05350371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05350371.